LIMUCAN
DEAD

Serial Number

88717535

Owner

Limucan GmbH

Attorney

Mark A. Wright

Filing Date

Dec 6, 2019

Add to watchlist:

No watchlists yet
View on USPTO

LIMUCAN Trademark

Serial Number: 88717535

LIMUCAN is a trademark filed by Limucan GmbH on December 6, 2019. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Limucan GmbH

Kleines Feld 17
Marl 49448 , DE

Entity Type: 16

Trademark Details

Filing Date

December 6, 2019

Registration Date

Not Registered

Goods & Services

Antioxidants as a dietary supplement; Bee pollen as a dietary supplement; Dietary food supplements for pets; Dietary food supplements for pets in powder form for dissolving in liquid; Dietary food supplements; Dietetic preparations and nutritional supplements; Dietary and nutritional supplements; Ground flax fiber for use as a dietary supplement; Functional foods for use as dietary supplements; Fruit flavored drink powder as a nutritional supplement; Glucose for use as a nutritional supplement for medical purposes; Mainly calcium supplements; Calcium tablets as a dietary supplement; Medicated nutritional supplements; Mineral supplements; Mineral nutritional supplements for humans; Dietary supplement drinks; Food supplements; Dietary supplements based on minerals; Dietary supplements based on wheat; Dietary supplements based on zinc; Dietary supplements of albumin; Food supplements of alginates; Dietary supplements of amino acids; Nutritional supplements of enzymes; Dietary supplement of royal jelly; Dietary supplements made from glucose; Food supplements made from glucose (glucose); Nutritional supplements of yeast; Dietary supplements of casein; Dietary supplements of flaxseed; Dietary supplements of flaxseed oil; Dietary supplements of lecithin; Nutritional supplements made from pollen; Nutritional supplements of propolis; Nutritional supplements of proteins; Dietary supplements of trace elements; Dietary supplements of starch for medical purposes; Dietary supplements made from vitamins; Nutritional supplements of wheat germ; Nutritional supplements for dietetic purposes; Nutritional supplements for medical purposes; Dietary supplements for humans; Dietary supplements for human beings, not for medical purposes; Dietary supplements for farm animal feed; Nutritional supplements for animals; Nutritional supplements for veterinary purposes; Dietary supplements for controlling cholesterol levels; Nutritional supplements; Nutritional supplements for persons who must follow a special diet; Nutritional supplements for babies; Nutritional supplements in the form of powdered drink mixes; Natural supplements for the treatment of claustrophobia; Non-medicated nutritional supplements; Nutrient energy bars as a dietary supplement; Soy isoflavone supplements; Soy protein containing food supplements; Veterinary nutritional supplements; Vitamin preparations in the form of nutritional supplements; Dietary supplements consisting primarily of iron; Dietary supplements consisting primarily of iron; Predominantly calcium supplements; Predominantly magnesium supplements; Nutritional supplements mainly consisting of magnesium; Dietary supplements consisting primarily of mushroom extracts; Dietary supplements consisting primarily of zinc; Drug-releasing enamel films which facilitate the administration of nutritional supplements; Drug-releasing coatings of tablets which facilitate the administration of nutritional supplements; Predominantly mineral supplements; Predominantly vitamin supplements

Fluid creams (cosmetics); Face wash (cosmetics); Skin masks (cosmetics); Cosmetics; cosmetic pencils

Retail services in relation to dietary supplements; Wholesale services in relation to dietary supplements

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 6, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 5, 2020 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 16, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 16, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 16, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 9, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 11, 2019 NWOS
NEW APPLICATION ENTERED
Dec 10, 2019 NWAP